webinar register page

Novartis Discusses the VIBRANT-HD Trial

Join us for an HDSA Research Webinar in which clinical leaders and Novartis representatives will talk about the VIBRANT-HD trial and the decision to stop development of branaplam in HD, and answer community questions. Speakers will include VIBRANT-HD clinical site investigator and chair of the trial Steering Committee Dr. Blair Leavitt, Director of Research and Consultant Neurologist at the UBC Centre for Huntington Disease; Medical lead for the branaplam program, Dr. Harry Ramos, Senior Clinical Development Medical Director at Novartis, and Clinical program head for the branaplam program, Dr. Beth Borowsky, Executive Director and Senior Global Program Clinical Head at Novartis.

Feb 22, 2023 12:00 PM in Eastern Time (US and Canada)